“…In addition, glucocorticoids in nearly one-third of the patients could cause adverse events including gastrointestinal bleeding, arterial hypertension, bone fracture, diabetes mellitus, body-weight increase, and increase mortality rate [ 6 ]. Successful treatment of steroid-resistant COP is reported when, in combination with steroids or alone, rituximab [ 12 ], azathioprine [ 4 , 10 ], cyclophosphamide, cyclosporine A [ 4 ], and mycophenolic acid [ 13 ] are applied [ 14 ].…”